Nilotinib (AMN107, trade name Tasigna), in the form of the hydrochloride
monohydrate salt, is a small-molecule tyrosine kinase inhibitor approved for the ...
Nilotinib may cause QT prolongation (an irregular heart rhythm that can lead to
fainting, loss of consciousness, seizures, or sudden death). Tell your doctor if you
Nov 30, 2015 ... Learn about the prescription medication Tasigna Capsules (Nilotinib Capsules),
drug uses, dosage, side effects, drug interactions, warnings, ...
See full prescribing information for. TASIGNA. TASIGNA® (nilotinib) Capsules for
oral use. Initial U.S. Approval: 2007. WARNING: QT PROLONGATION AND ...
Oct 21, 2015 ... The NPF Recommends Further Study but Not Clinical Use of this Investigational
Drug. Tasigna (Nilotinib) is a leukemia drug that has recently ...
May 27, 2015 ... Information on the drug nilotinib (Tasigna) prescribed for the treatment of
leukemia. Side effects, drug interactions, dosing information, and ...
Nilotinib, also known as AMN107, is a tyrosine kinase inhibitor under
investigation as a possible treatment for chronic myelogenous leukemia (CML).
In June ...
(nye-LOE-ti-nib). Generic Name: nilotinib. Trade Name(s): Tasigna. Nilotinib is
the generic for the trade chemotherapy drug Tasigna. In some cases, health care
Medscape - Chronic myeloid leukemia (CML) dosing for Tasigna (nilotinib),
frequency-based adverse effects, comprehensive interactions, contraindications,
Tasigna (nilotinib) is a cancer treatment for adult patients with newly diagnosed
Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in the ...